Refractory Breast cancer

Drug	Drug Name	Drug Description
DB00570	Vinblastine	A vinca alkaloid used to treat breast cancer, testicular cancer, neuroblastoma, Hodgkin's and non-Hodgkins lymphoma, mycosis fungoides, histiocytosis, and Kaposi's sarcoma.

Drug	Drug Name	Target	Type
DB00570	Vinblastine	Tubulin beta chain	target
DB00570	Vinblastine	Transcription factor AP-1	target
DB00570	Vinblastine	Cytochrome P450 3A4	enzyme
DB00570	Vinblastine	P-glycoprotein 1	transporter
DB00570	Vinblastine	Multidrug resistance-associated protein 1	transporter
DB00570	Vinblastine	Canalicular multispecific organic anion transporter 1	transporter
DB00570	Vinblastine	Multidrug resistance-associated protein 6	transporter
DB00570	Vinblastine	Bile salt export pump	transporter
DB00570	Vinblastine	Tubulin alpha-1A chain	target
DB00570	Vinblastine	Tubulin delta chain	target
DB00570	Vinblastine	Tubulin epsilon chain	target
DB00570	Vinblastine	Tubulin gamma-1 chain	target
DB00570	Vinblastine	Cytochrome P450 2D6	enzyme
DB00570	Vinblastine	Solute carrier organic anion transporter family member 1B1	transporter

Drug	Drug Name	Phase	Status	Count